Effect of meprobamate on the multiplication of Brucella abortus in monocytes

Area of Science:

• Immunology
• Pharmacology
• Microbiology

Background:

• Mononuclear phagocytes (monocytes) play a crucial role in host defense against bacterial infections.
• Brucella abortus is an intracellular pathogen that can evade host immune responses.
• Meprobamate is a centrally acting muscle relaxant and anxiolytic drug.

Purpose of the Study:

• To investigate the effect of meprobamate on the interaction between guinea pig peritoneal mononuclear phagocytes and Brucella abortus.
• To determine whether meprobamate directly or indirectly affects monocyte-mediated intracellular bacterial growth.
• To elucidate the role of serum components in mediating the observed effects.

Main Methods:

• Isolation of peritoneal mononuclear phagocytes from meprobamate-treated and untreated guinea pigs.
• In vitro culture of Brucella abortus within monocytes.
• Assessment of intracellular bacterial growth.
• Evaluation of serum-mediated effects and direct drug-bacteria/monocyte interactions.

Main Results:

• Monocytes from meprobamate-treated guinea pigs exhibited reduced intracellular growth of smooth Brucella abortus compared to controls.
• Direct in vitro exposure of monocytes or bacteria to meprobamate did not alter bacterial growth.
• Serum from meprobamate-exposed animals was necessary for the observed inhibition of intracellular bacterial growth.
• No increase in the brucellacidal activity of serum from meprobamate-treated animals was observed.

Conclusions:

• Meprobamate indirectly enhances the ability of monocytes to control intracellular Brucella abortus growth.
• The effect is mediated by serum factors and requires an interaction between monocytes and these serum components.
• This study highlights a novel immunomodulatory effect of meprobamate, independent of its direct antimicrobial or cellular activity.